CA2819174A1 - Solid phase extraction method - Google Patents
Solid phase extraction method Download PDFInfo
- Publication number
- CA2819174A1 CA2819174A1 CA2819174A CA2819174A CA2819174A1 CA 2819174 A1 CA2819174 A1 CA 2819174A1 CA 2819174 A CA2819174 A CA 2819174A CA 2819174 A CA2819174 A CA 2819174A CA 2819174 A1 CA2819174 A1 CA 2819174A1
- Authority
- CA
- Canada
- Prior art keywords
- water
- compound
- etoh
- spe
- aliquot
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000002414 normal-phase solid-phase extraction Methods 0.000 title claims abstract description 83
- 238000000034 method Methods 0.000 title claims abstract description 78
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 208
- 150000001875 compounds Chemical class 0.000 claims description 80
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 46
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 36
- 239000002904 solvent Substances 0.000 claims description 35
- 239000003960 organic solvent Substances 0.000 claims description 30
- 239000002594 sorbent Substances 0.000 claims description 27
- 239000002243 precursor Substances 0.000 claims description 25
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 16
- KRHYYFGTRYWZRS-BJUDXGSMSA-M fluorine-18(1-) Chemical compound [18F-] KRHYYFGTRYWZRS-BJUDXGSMSA-M 0.000 claims description 16
- 239000011541 reaction mixture Substances 0.000 claims description 14
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 9
- 150000002430 hydrocarbons Chemical class 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- 238000011068 loading method Methods 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 5
- 230000001143 conditioned effect Effects 0.000 claims description 5
- 229930195733 hydrocarbon Natural products 0.000 claims description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 5
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims description 5
- 230000003750 conditioning effect Effects 0.000 claims description 4
- 125000003725 azepanyl group Chemical group 0.000 claims description 3
- 238000009826 distribution Methods 0.000 claims description 3
- 125000002757 morpholinyl group Chemical group 0.000 claims description 3
- 125000003386 piperidinyl group Chemical group 0.000 claims description 3
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 3
- 125000001475 halogen functional group Chemical group 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 238000005342 ion exchange Methods 0.000 claims description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 2
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 150000002431 hydrogen Chemical group 0.000 claims 1
- 238000000746 purification Methods 0.000 abstract description 25
- -1 indole compound Chemical class 0.000 abstract description 9
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract description 3
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 abstract description 3
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 abstract description 3
- 229940125904 compound 1 Drugs 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 21
- 238000002474 experimental method Methods 0.000 description 17
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 15
- 239000012535 impurity Substances 0.000 description 15
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 15
- 229920002554 vinyl polymer Polymers 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 11
- 238000002372 labelling Methods 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000003643 water by type Substances 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- 150000002440 hydroxy compounds Chemical class 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 125000003545 alkoxy group Chemical group 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 235000019253 formic acid Nutrition 0.000 description 5
- 230000027455 binding Effects 0.000 description 4
- 150000002475 indoles Chemical class 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 239000012216 imaging agent Substances 0.000 description 3
- 238000011503 in vivo imaging Methods 0.000 description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 3
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- NLMDJJTUQPXZFG-UHFFFAOYSA-N 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane Chemical compound C1COCCOCCNCCOCCOCCN1 NLMDJJTUQPXZFG-UHFFFAOYSA-N 0.000 description 2
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 2
- HWTDMFJYBAURQR-UHFFFAOYSA-N 80-82-0 Chemical compound OS(=O)(=O)C1=CC=CC=C1[N+]([O-])=O HWTDMFJYBAURQR-UHFFFAOYSA-N 0.000 description 2
- 101100416200 Caenorhabditis elegans rla-0 gene Proteins 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000002739 cryptand Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- UQSQSQZYBQSBJZ-UHFFFAOYSA-N fluorosulfonic acid Chemical compound OS(F)(=O)=O UQSQSQZYBQSBJZ-UHFFFAOYSA-N 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- GXHMMDRXHUIUMN-UHFFFAOYSA-N methanesulfonic acid Chemical compound CS(O)(=O)=O.CS(O)(=O)=O GXHMMDRXHUIUMN-UHFFFAOYSA-N 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 150000005621 tetraalkylammonium salts Chemical class 0.000 description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 102000004300 GABA-A Receptors Human genes 0.000 description 1
- 108090000839 GABA-A Receptors Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 208000036110 Neuroinflammatory disease Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- FYJKEHKQUPSJDH-UHFFFAOYSA-N [dimethyl-(trimethylsilylamino)silyl]methane;potassium Chemical compound [K].C[Si](C)(C)N[Si](C)(C)C FYJKEHKQUPSJDH-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000010504 bond cleavage reaction Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229940125890 compound Ia Drugs 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 238000003682 fluorination reaction Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- BCVXHSPFUWZLGQ-UHFFFAOYSA-N mecn acetonitrile Chemical compound CC#N.CC#N BCVXHSPFUWZLGQ-UHFFFAOYSA-N 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- GVOISEJVFFIGQE-YCZSINBZSA-N n-[(1r,2s,5r)-5-[methyl(propan-2-yl)amino]-2-[(3s)-2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 GVOISEJVFFIGQE-YCZSINBZSA-N 0.000 description 1
- 230000003959 neuroinflammation Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000012421 spiking Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/84—Separation, e.g. from tar; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42311410P | 2010-12-15 | 2010-12-15 | |
| US61/423,114 | 2010-12-15 | ||
| GB1021263.7 | 2010-12-15 | ||
| GBGB1021263.7A GB201021263D0 (en) | 2010-12-15 | 2010-12-15 | Solid phase extraction method |
| PCT/EP2011/072781 WO2012080349A1 (en) | 2010-12-15 | 2011-12-14 | Solid phase extraction method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2819174A1 true CA2819174A1 (en) | 2012-06-21 |
Family
ID=43567233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2819174A Abandoned CA2819174A1 (en) | 2010-12-15 | 2011-12-14 | Solid phase extraction method |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9061996B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2651857B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6348282B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20130125780A (cg-RX-API-DMAC7.html) |
| CN (1) | CN103249698B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011343347A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112013012686A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2819174A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201021263D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL226335A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2013006817A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ611988A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2013124955A (cg-RX-API-DMAC7.html) |
| SG (1) | SG190911A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012080349A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150088802A (ko) * | 2012-11-30 | 2015-08-03 | 지이 헬쓰케어 리미티드 | 트리시클릭 인돌 유도체의 결정화 방법 |
| GB201312768D0 (en) | 2013-07-17 | 2013-08-28 | Ge Healthcare Ltd | Work-up procedure |
| KR102234143B1 (ko) * | 2013-08-22 | 2021-03-31 | 지이 헬쓰케어 리미티드 | [18f]-플루오로알킬 토실레이트의 개선된 합성 |
| GB201411571D0 (en) * | 2014-06-30 | 2014-08-13 | Ge Healthcare Ltd | Radiolabelling method |
| GB2531602A (en) * | 2014-10-24 | 2016-04-27 | Ge Oil & Gas Uk Ltd | Optical amplifier for subsea control systems |
| JP6842415B2 (ja) | 2014-12-04 | 2021-03-17 | ジーイー・ヘルスケア・リミテッド | 放射性医薬品からアセトアルデヒドを除去する方法 |
| GB201805253D0 (en) | 2018-03-29 | 2018-05-16 | Ge Healthcare Ltd Ip | Solid phase extraction |
| GB201919016D0 (en) * | 2019-12-20 | 2020-02-05 | Ge Healthcare Ltd | Apparatus and method for solid phase extraction |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004279192A (ja) * | 2003-03-14 | 2004-10-07 | Sumitomo Heavy Ind Ltd | 放射能予測装置、放射能予測方法、及び、標識化合物製造装置 |
| WO2005025519A2 (en) * | 2003-09-11 | 2005-03-24 | Mayo Foundation For Medical Education And Research | Radiolabeled thymidine solid-phase extraction purification method |
| US20070219618A1 (en) | 2006-03-17 | 2007-09-20 | Cully Edward H | Endoprosthesis having multiple helically wound flexible framework elements |
| WO2008110757A1 (en) * | 2007-03-09 | 2008-09-18 | Ge Healthcare Limited | Separation process |
| GB0905328D0 (en) * | 2009-03-27 | 2009-05-13 | Ge Healthcare Ltd | Indole derivatives |
-
2010
- 2010-12-15 GB GBGB1021263.7A patent/GB201021263D0/en not_active Ceased
-
2011
- 2011-12-14 EP EP11802893.5A patent/EP2651857B1/en active Active
- 2011-12-14 JP JP2013543766A patent/JP6348282B2/ja active Active
- 2011-12-14 BR BR112013012686A patent/BR112013012686A2/pt not_active IP Right Cessation
- 2011-12-14 CN CN201180060305.6A patent/CN103249698B/zh active Active
- 2011-12-14 MX MX2013006817A patent/MX2013006817A/es not_active Application Discontinuation
- 2011-12-14 KR KR1020137015313A patent/KR20130125780A/ko not_active Withdrawn
- 2011-12-14 RU RU2013124955/04A patent/RU2013124955A/ru not_active Application Discontinuation
- 2011-12-14 AU AU2011343347A patent/AU2011343347A1/en not_active Abandoned
- 2011-12-14 NZ NZ611988A patent/NZ611988A/en not_active IP Right Cessation
- 2011-12-14 CA CA2819174A patent/CA2819174A1/en not_active Abandoned
- 2011-12-14 WO PCT/EP2011/072781 patent/WO2012080349A1/en not_active Ceased
- 2011-12-14 US US13/993,108 patent/US9061996B2/en active Active
- 2011-12-14 SG SG2013041116A patent/SG190911A1/en unknown
-
2013
- 2013-05-13 IL IL226335A patent/IL226335A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN103249698B (zh) | 2016-08-10 |
| KR20130125780A (ko) | 2013-11-19 |
| CN103249698A (zh) | 2013-08-14 |
| MX2013006817A (es) | 2013-12-06 |
| EP2651857B1 (en) | 2017-02-15 |
| BR112013012686A2 (pt) | 2016-09-06 |
| IL226335A0 (en) | 2013-07-31 |
| EP2651857A1 (en) | 2013-10-23 |
| SG190911A1 (en) | 2013-07-31 |
| JP2014506874A (ja) | 2014-03-20 |
| US9061996B2 (en) | 2015-06-23 |
| GB201021263D0 (en) | 2011-01-26 |
| NZ611988A (en) | 2015-07-31 |
| US20130261315A1 (en) | 2013-10-03 |
| JP6348282B2 (ja) | 2018-06-27 |
| RU2013124955A (ru) | 2015-01-20 |
| AU2011343347A1 (en) | 2013-06-06 |
| WO2012080349A1 (en) | 2012-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2651857B1 (en) | Solid phase extraction method | |
| EP2070897B1 (en) | Method of rapid methylation, kit for preparing pet tracer and method of producing pet tracer | |
| JP2007532524A (ja) | フッ素化方法 | |
| Wang et al. | Synthesis of [11C] PBR06 and [18F] PBR06 as agents for positron emission tomographic (PET) imaging of the translocator protein (TSPO) | |
| Pretze et al. | Automated preparation of [18F] AFP and [18F] BFP: Two novel bifunctional 18F-labeling building blocks for Huisgen-click | |
| CN106458785A (zh) | 新制剂及合成方法 | |
| KR20120034724A (ko) | 저압 내지 중간압 액체 크로마토그래피의 사용에 의한 방사성추적자의 정제 | |
| Wüst et al. | No‐carrier added synthesis of 18F‐labelled nucleosides using Stille cross‐coupling reactions with 4‐[18F] fluoroiodobenzene | |
| Samuelsson et al. | Synthesis of 1‐(2′‐deoxy‐2′‐fluoro‐β‐D‐arabinofuranosyl)‐[Methyl‐11C] thymine ([11C] FMAU) via a Stille cross‐coupling reaction with [11C] methyl iodide | |
| Gao et al. | A new high-yield synthetic route to PET CB1 radioligands [11C] OMAR and its analogs | |
| Knott et al. | Simplified and automatic one‐pot synthesis of 16α‐[18F] fluoroestradiol without high‐performance liquid chromatography purification | |
| Alonso Martinez et al. | Development of a novel [18F] fluorobenzyl derivative of the AT1 receptor antagonist Candesartan | |
| Gao et al. | Facile and high-yield synthesis of N-(4-diethylamino) benzyl-4-[11C] methoxy-N-(p-tolyl) benzenesulfonamide as a new potential PET selective CB2 radioligand | |
| Donovan et al. | A convenient solution-phase method for the preparation of meta-iodobenzylguanidine in high effective specific activity | |
| HK1188207A (zh) | 固相萃取方法 | |
| Tietze et al. | Syntheses and radiofluorination of two derivatives of 5‐cyano‐indole as selective ligands for the dopamine subtype‐4 receptor | |
| Pijarowska‐Kruszyna et al. | Synthesis of novel halo and tosyloxy nortropane derivatives as efficient precursors for the one‐step synthesis of the dopamine transporter PET ligand [18F] FECNT | |
| CN112341464A (zh) | 一种卤素取代的拉曲替尼化合物 | |
| Thonon et al. | Photoactivated 1, 3-dipolar cycloaddition for the rapid preparation of 18F labelled radiotracers | |
| EP3036209B1 (en) | An improved synthesis of [18f]- fluoroalkyl tosylate | |
| Ran et al. | Radiolabeling of 1-[N', N'-bis (2-chloroethyl)-4-aminophenyl]-N-methyl-fullereno-C 60-[1, 9-c] pyrrolidine with 125 I | |
| JP2019218302A (ja) | アリールボロン酸誘導体の製造方法、および該アリールボロン酸誘導体を用いた放射性フッ素標識化合物の製造方法 | |
| KR20140069001A (ko) | [18f]플루오로메틸 브로마이드의 단순화된 방사합성 | |
| Spang et al. | Synthesis and [11C]‐radiolabelling of dechloro‐epibatidine and 2PABH, two potential radioligands for studying the central nAChRs in vivo | |
| WO2021167008A1 (ja) | 芳香族アスタチン化合物の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20161214 |